SCHEMBL5697563

SCHEMBL5697563

Cc1cn(C2O[C@H](CO)[C@@H](O)[C@@H]2OF)c(=O)nc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
MTOR P42345 2/20 0.46
ALDH1A1 P00352 2/20 0.46
THRB P10828 1/20 0.46
MDM2 Q00987 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
GMNN O75496 1/20 0.46
TP53 P04637 1/20 0.46
NFKB1 P19838 1/20 0.46
DNMT1 P26358 1/20 0.46
THPO P40225 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
BLM P54132 1/20 0.46
HBB P68871 1/20 0.46
PMP22 Q01453 1/20 0.46
TK2 O00142 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2338693 1.00 LMNA (0.46) LMNAMTORALDH1A1THRBMDM2
SCHEMBL7194470 1.00 LMNA (0.46) LMNAMTORALDH1A1THRBMDM2
SCHEMBL5425984 0.90 LMNA (0.46) LMNAMTORALDH1A1THRBMDM2
SCHEMBL18512865 0.90 LMNA (0.47) LMNAMTORALDH1A1THRBMDM2
SCHEMBL22261563 0.90 LMNA (0.47) LMNAMTORALDH1A1THRBMDM2
SCHEMBL15810727 0.90 LMNA (0.47) LMNAMTORALDH1A1THRBMDM2
SCHEMBL659090 0.90 LMNA (0.47) LMNAMTORALDH1A1THRBMDM2
SCHEMBL659091 0.90 LMNA (0.47) LMNAMTORALDH1A1THRBMDM2
SCHEMBL16805336 0.90 LMNA (0.47) LMNAMTORALDH1A1THRBMDM2
SCHEMBL28738894 0.89 LMNA (0.46) LMNAMTORALDH1A1THRBMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1668023-A1 B-L-NUCLEOSIDES AND USE THEREOF AS PHARMACEUTICAL AGENTS FOR TREATING VIRAL DISEASES MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 2006-06-14 EP disclosed
WO-2005026186-A1 Β-L-NUCLEOSIDES AND USE THEREOF AS PHARMACEUTICAL AGENTS FOR TREATING VIRAL DISEASES Max-Delbrück-Centrum für Molekulare Medizin (DE) 2005-03-24 WO disclosed